Compare BIVI & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIVI | MRM |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 9.3M |
| IPO Year | 2013 | 2020 |
| Metric | BIVI | MRM |
|---|---|---|
| Price | $1.62 | $0.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 196.6K | 8.4K |
| Earning Date | 05-11-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.06 | $0.90 |
| 52 Week High | $6.01 | $4.45 |
| Indicator | BIVI | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 43.66 |
| Support Level | $1.20 | $0.92 |
| Resistance Level | $1.67 | $1.02 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 56.14 | 46.08 |
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.